<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6893968\results\search\disease\results.xml">
  <result pre="epidemics. The unavailability of a specific antiviral drug against the" exact="chikungunya" post="virus (CHIKV) disease has created an alarming situation to"/>
  <result pre="remedial management to preclude CHIKV infection. Introduction The cases of" exact="chikungunya" post="viral fever are burgeoning every year. Infections are not"/>
  <result pre="only limited to Asia and Africa; recently, the epidemics of" exact="chikungunya" post="have been reported from Central and South America.1,2 Concerning"/>
  <result pre="studies have shown that there is considerable resource burden from" exact="chikungunya" post="outbreaks, which escalates in monsoon and post-monsoon seasons. Therefore,"/>
  <result pre="which escalates in monsoon and post-monsoon seasons. Therefore, cases of" exact="chikungunya" post="viral fever have increased in the continent of Asia"/>
  <result pre="of Asia and various parts of the world. The name" exact="chikungunya" post="originates from &quot;Makonde�?, meaning &quot;to become twisted�?. It denotes"/>
  <result pre="of those going through joint ache as a result of" exact="chikungunya" post="infection. Chikungunya virus (CHIKV) spreads by mosquito vectors Aedes"/>
  <result pre="manifestation is one of the bases for the diagnosis of" exact="chikungunya" post="infection, but the confirmation of disease can only be"/>
  <result pre="viruses like Ross River virus, Sindbis virus (SINV), Western equine" exact="encephalitis" post="virus (WEEV), Semiliki Forest virus (SFV), Venezuelan equine encephalitis"/>
  <result pre="equine encephalitis virus (WEEV), Semiliki Forest virus (SFV), Venezuelan equine" exact="encephalitis" post="virus (VEEV), etc. They are furthermore categorized into Old"/>
  <result pre="regressed the catalytically inactivated mutants. Despite the increasing number of" exact="chikungunya" post="patients, haplessly, to date, no antiviral remedy or vaccine"/>
  <result pre="to curb CHIKV progress have failed to produce noteworthy therapeutic" exact="aids" post="in clinical samples.21−24 In the recent past, high-throughput assays"/>
  <result pre="obtained dihydrorugosaflavonoids (Scheme 1).30,31 We had screened these compounds for" exact="tuberculosis" post="in our previous studies, and we found that halogenated"/>
  <result pre="analogues. In positive-strand RNA viruses such as alphaviruses, coronaviruses, and" exact="hepatitis" post="E virus, the macrodomains are the integral part of"/>
  <result pre="antigen. One of the two envelope glycoproteins present in the" exact="chikungunya" post="virus named E2 glycoprotein has been used as the"/>
  <result pre="clearly show the potential of these two compounds in the" exact="suppression" post="of viral RNA levels in infected cells. Furthermore, the"/>
  <result pre="treat. Curr. Opin. Virol.2017, 24, 25–30. 10.1016/j.coviro.2017.03.016.28414993 MorrisonT. E.Reemergence of" exact="chikungunya" post="virus. J. Virol.2014, 88, 11644–11647. 10.1128/JVI.01432-14.25078691 National Vector Borne"/>
  <result pre="709–712. 10.1038/nature09555.21124458 ShermanM. B.; WeaverS. C.Structure of the recombinant alphavirus" exact="western equine encephalitis" post="virus revealed by cryoelectron microscopy. J. Virol.2010, 84, 9775–9782."/>
  <result pre="ShermanM. B.; WeaverS. C.Structure of the recombinant alphavirus western equine" exact="encephalitis" post="virus revealed by cryoelectron microscopy. J. Virol.2010, 84, 9775–9782."/>
  <result pre="276, 148–160. 10.1006/viro.2000.0544.11022003 SharmaR.; KesariP.; KumarP.; TomarS.Structure function insights into" exact="chikungunya" post="virus capsid protein: Small molecules targeting capsid hydrophobic pocket."/>
  <result pre="synthesis of rugosaflavonoid and its derivatives and their activatity agahinst" exact="breast cancer." post="RSC Adv.2017, 7, 33052–33060. 10.1039/C7RA04971D. PuranikN. V.; SrivastavaP.; SwamiS.;"/>
  <result pre="MeritsA.; AholaT.; McInerneyG. M.Differential PI3K-Akt-mTOR activation by Semliki Forest and" exact="chikungunya" post="virus, dependent on nsP3 and connected to replication complex"/>
  <result pre="W.Computer-assisted assignment of functional domains in the nonstructural polyprotein of" exact="hepatitis" post="E virus: delineation of an additional group of positive-strand"/>
  <result pre="Rev. Biochem.2016, 85, 431–454. 10.1146/annurev-biochem-060815-014935.26844395 ErikssonK. K.; Cervantes-BarragánL.; LudewigB.; ThielV.Mouse" exact="hepatitis" post="virus liver pathology is dependent on ADP-ribose-1″-phosphatase, a viral"/>
  <result pre="DavidsonA. D.; SiddellS. G.; ThielV.; ZiebuhrJ.; WeberF.The ADP-ribose-1″-monophosphatase domains of" exact="severe acute respiratory syndrome" post="coronavirus and human coronavirus 229E mediate resistance to antiviral"/>
  <result pre="macrodomain promotes virulence and suppresses the innate immune response during" exact="severe acute respiratory syndrome" post="coronavirus infection. mBio2016, 7, e01721-1610.1128/mBio.01721-16.27965448 RungrotmongkolT.; NunthabootN.; MalaisreeaM.; KaiyawetN.;"/>
  <result pre="specific binding of ADP-ribose to the nsP3 macro domains of" exact="chikungunya" post="and venezuelan equine encephalitis viruses: Molecular dynamics simulations and"/>
  <result pre="of ADP-ribose to the nsP3 macro domains of chikungunya and" exact="venezuelan equine encephalitis" post="viruses: Molecular dynamics simulations and free energy calculations. J."/>
  <result pre="to the nsP3 macro domains of chikungunya and venezuelan equine" exact="encephalitis" post="viruses: Molecular dynamics simulations and free energy calculations. J."/>
  <result pre="protease. Biochimie2018, 149, 51–61. 10.1016/j.biochi.2018.04.004.29635044 KaurR.; MudgalR.; JoseJ.; KumarP.; TomarS.Glycan-dependent" exact="chikungunya" post="viral infection divulged by antiviral activity of NAG specific"/>
 </snippets>
</snippetsTree>
